Results 131 to 140 of about 20,113 (176)
Some of the next articles are maybe not open access.

Ivermectine

Annales de Dermatologie et de Vénéréologie, 2004
Ivermectin is a semi-synthetic derivative of a macrocyclic lactone. It causes paralysis in many nematodes and arthropodes because of its effect on ion-channels in cell membranes. Ivermectin was first used in veterinary medicine. In man, it was shown to be microfilaricid against Onchocerca volvulus. Most of the adverse reactions following treatment were
openaire   +2 more sources

Ivermectin resistance

Parasitology Today, 1993
In this review of ivermectin resistance, Wesley Shoop discusses the definition of resistance, catalogs all known cases of ivermectin resistance, argues that overmectins and milbemycins belong in the same action family, discusses the possibility of resistance in the filariae, and suggests that detection of ivermectin resistance is the area where future ...
openaire   +2 more sources

Pharmacology of ivermectin

Parasitology Today, 1988
Ivermectin is a semi-synthetic macrocyclic lactone (Fig. I) active in single low doses against many parasites - particularly nematodes and arthropods. It has been registered for animal health use since early 1985, and was earlier this year approved for human use by the French Directorate o f Pharmacy and Drugs.
J L, Bennett, J F, Williams, V, Dave
openaire   +2 more sources

Ivermectin

Reactions Weekly, 2015
Francisco Vega-Lopez, Sara Ritchie
  +4 more sources

Ivermectin

Reactions Weekly, 1993
  +4 more sources

Effect of Early Treatment with Ivermectin among Patients with Covid-19

New England Journal of Medicine, 2022
Gilmar Reis   +2 more
exaly  

[Ivermectin].

Medecine tropicale : revue du Corps de sante colonial, 2005
Initial clinical trials in 1980 showed that ivermectin was remarkably effective against Onchocerca volvulus. Some 25 years after more than 50 million people are treated annually with Mectizan mainly within the framework of the African Programme for Onchocerciasis Control (APOC).
openaire   +1 more source

Home - About - Disclaimer - Privacy